Pharmacyte Biotech Inc's Customers Performance

Name: Pharmacyte Biotech Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

PMCB

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


PMCB's Source of Revenues		• List of PMCB Customers

for the same period Pharmacyte Biotech Inc

• List of PMCB Customers

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Pharmacyte Biotech Inc's Comment on Sales, Marketing and Customers

The company relies on Austrianova as its sole manufacturer for product candidates, specifically handling the encapsulation process of cells for oncology applications. Austrianova is responsible for procuring all necessary raw materials, including cellulose sulfate, used in the proprietary encapsulation process. The company licenses technology and trademarks related to live cell encapsulation and the treatment of solid cancerous tumors. Customers and market segments mentioned include Austrianova and SG Austria.

News about Pharmacyte Biotech Inc Contracts

PharmaCyte Biotech Joins Forces with MyMD Pharmaceuticals with a $7 Million Investment to Revolutionize Inflammatory Disease Therapies

PharmaCyte Biotech Invests $7 Million in MyMD Pharmaceuticals to Develop Novel Therapies for Inflammatory DiseasesPharmaCyte Biotech, a renowned biotechnology company specializing in cellular therapies for various diseases, has made a strategic investment of $7 million in MyMD Pharmaceuticals, a clinical-stage biopharmaceutical company focused on addressing age-related diseases, autoimmune disorders, and inflammatory conditions. This investment highlights the strong commitment of both companies to advancing innovative treatments for patients suffering from these challenging health ailments.The announcement of this investment comes on the heels of MyMD s impressive results from a Phase 2 clinical trial of its...

Pharmacyte Biotech Inc’s Comment on Sales, Marketing and Customers

PMCB's Stock Performance relative to it's Customers

PMCB's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Pharmacyte Biotech Inc	3.82	0.00	-10.14	2
SUBTOTAL	0.00	0.00	0.00	-

Sources: Pharmacyte Biotech Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Pharmacyte Biotech Inc’s corporate clients.
For your research, we’ve provided 9 tables on Pharmacyte Biotech Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.